CMC Strategy for Advancing mRNA Therapeutics for Rare Diseases

Time: 11:00 am
day: Day One

Details:

  • Considerations and challenges using mRNA for rare disease indication
  • Improving integrity and reducing impurities in drug substance development
  • Considerations in early and late-stage CMC development

Speakers: